Breaking News Instant updates and real-time market news.

TWTR

Twitter

$23.52

-0.48 (-2.00%)

, CRM

Salesforce

$72.63

2.11 (2.99%)

19:07
10/04/16
10/04
19:07
10/04/16
19:07

Twitter to field bids this week, Salesforce among suitors, WSJ says

Twitter (TWTR) is expected to field takeover offers this week, reports the Wall Street Journal, citing sources. Salesforce (CRM) is among the bidders, the sources told the Journal, adding that Alphabet (GOOG) could submit an offer and that Disney (DIS) has also been weighing a bid. Salesforce CEO Marc Benioff views Twitter as an unpolished gem with unrealized potential in advertising, ecommerce, and other data-reliant fields he believes are important to Salesforce's future growth, the sources told the Journal. The report notes that Twitter could be priced upward of $20B. Reference Link

TWTR

Twitter

$23.52

-0.48 (-2.00%)

CRM

Salesforce

$72.63

2.11 (2.99%)

GOOG

Alphabet

$776.43

3.87 (0.50%)

GOOGL

Alphabet Class A

$802.79

2.41 (0.30%)

DIS

Disney

$92.59

0.1 (0.11%)

  • 04

    Oct

  • 04

    Oct

  • 23

    Oct

  • 27

    Oct

  • 10

    Nov

  • 30

    Nov

  • 15

    Jan

TWTR Twitter
$23.52

-0.48 (-2.00%)

10/04/16
SUSQ
10/04/16
NO CHANGE
Target $15
SUSQ
Neutral
Upside potential for Twitter takeout already captured, says Susquehanna
Susquehanna analyst Shyam Patil analyzed the potential takeout range for a Twitter buyout and believes most of the potential upside has already been captured. He sees the takeout range in the $17-$24 range and with the stock trading at $24, sees little upside. Patil recommends selling Twitter before market share losses to Snap play out as its fundamentals have deteriorated significantly since going public. Patil reiterated his Neutral rating and $15 price target on Twitter shares.
09/28/16
09/28/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Underperform from Neutral at Wedbush with analyst James Dix citing concerns that the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive. 2. AT&T (T) downgraded to Neutral from Buy at UBS with analyst John Hodulik citing expectations for lower earnings growth. 3. Macy's (M) downgraded to Neutral from Outperform at Credit Suisse with analyst Michael Exstein saying the retailer, after outlining in August its operations and merchandising strategies, is now in an execution phase. 4. Twitter (TWTR) downgraded to Underperform from Neutral at Mizuho and to Sell from Hold at Loop Capital. 5. Galectin Therapeutics (GALT) downgraded to Sell from Buy at Roth Capital with analyst Sa'ar Yaniv citing the company's announcement that NASH-FX, GR-MD-02's Phase 2a study in NASH fibrosis, failed both primary and secondary endpoints. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/28/16
SBSH
09/28/16
NO CHANGE
SBSH
Buy
Citi hopes Disney does not acquire Twitter
Citi analyst Jason Bazinet lays out four reasons for why he doesn't like Disney (DIS) pursuing an acquisition of Twitter (TWTR). Going back 15 years, the analyst can't think of a single web-based property that was successfully acquired by a traditional media firm. Two, he calls Twitter trends "troubling." Three, Bazinet estimates a cash offer would lower Disney's stock by $5 per share while an equity offer would drop its stock by $9. Four, the analyst feels it is unclear how Disney's content will help Twitter. Bazinet thinks both Yahoo (YHOO) and Twitter lost "significant money" when they streamed NFL content over the web. The analyst hopes Twitter is acquired by somebody other than Disney. He keeps a Buy rating on Disney shares. Both Loop Capital and Mizuho this morning downgraded Twitter to sell ratings.
09/28/16
MZHO
09/28/16
DOWNGRADE
Target $15
MZHO
Underperform
Mizuho cuts Twitter to Underperform with $15 price target
Mizuho analyst Neil Doshi downgraded Twitter to Underperform from Neutral based on valuation. The shares are up 45% since the company reported Q2 results, primarily driven by potential buyout comments in media reports, Doshi tells investors in a research note. The stock at current levels is overvalued as Twitter's business fundamentals "have deteriorated significantly" over the past 12 months, the analyst contends. Doshi believes many of the M&A scenarios are unlikely to play out. He puts potential acquirers Salesforce (CRM) and Alphabet (GOOG, GOOGL) in the "maybe" camp, but he still has some reservations about these deals happening. The analyst believes investors of both companies would view a buyout of Twitter as negative. Doshi keeps a $15 price target for Twitter shares. The stock closed yesterday up 35c to $23.72. Loop Capital this morning also downgraded Twitter to Sell.
CRM Salesforce
$72.63

2.11 (2.99%)

09/27/16
SBSH
09/27/16
NO CHANGE
Target $16
SBSH
Neutral
Citi sees 40% downside in Twitter with no takeover bid
Citi analyst Mark May believes Twitter's (TWTR) risk/reward skews to the downside following the recent rally in the shares. A buyout of the company carries "strategic rationale for certain companies," but Twitter's "struggles and steep valuation" make a deal at a meaningful premium less likely, May tells investors in a research note. A takeover at $26 per share looks aggressive, May contends. He believes the stock could retest the lows of late May, representing 40% downside from current levels, should an acquisition offer not materialize. The analyst keeps a Neutral rating on Twitter with a $16 price target. The shares closed yesterday up 75c to $23.37 following reports that Disney (DIS) may be joining the list of potential acquires that already includes Alphabet (GOOG) and Salesforce (CRM).
09/30/16
LEHM
09/30/16
NO CHANGE
Target $89
LEHM
Overweight
Barclays says Salesforce deserves a fresh look ahead of Dreamforce conference
Barclays analyst Raimo Lenschow said Salesforce (CRM) deserves a "fresh look" ahead of the Dreamforce conference and analyst day. The analyst said investor sentiment has weakened following slightly lower Q2 results and speculation it could acquire Twitter (TWTR). Lenschow said there is a low likelihood of a Twitter acquisition and expects revenue growth to reaccelerate in 2H FY17 and notes the company is still growing in the low 20% range. The analyst said Salesforce is near the bottom of its 10 year valuation range and reiterates his Overweight rating and $89 price target on shares.
10/03/16
BMOC
10/03/16
NO CHANGE
BMOC
Salesforce removed from US Large Cap Fundamental List at BMO Capital
GOOG Alphabet
$776.43

3.87 (0.50%)

09/27/16
WEDB
09/27/16
DOWNGRADE
WEDB
Underperform
Alphabet downgraded to Underperform from Neutral at Wedbush
Wedbush analyst James Dix downgraded Alphabet to Underperform and lowered his price target on shares to $700 on concerns the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive.
09/27/16
WEDB
09/27/16
DOWNGRADE
WEDB
Underperform
Alphabet downgraded to Underperform from Neutral at Wedbush
GOOGL Alphabet Class A
$802.79

2.41 (0.30%)

09/30/16
RBCM
09/30/16
NO CHANGE
RBCM
Street underestimating Google growth outlook, says RBC Capital
RBC Capital analyst Mark Mahaney expects Google to end 2016 with "up to 20% growth," versus the Street's outlook of mid teen percentage level growth. Mahaney says that Google's growth should be boosted by "ongoing Search innovations, rising Mobile CPCs, and the growing impact of YouTube, Play & Cloud." He thinks that YouTube's revenue is growing at a 30%-40% clip. Mahaney raised his price target on the stock to $1,025 from $1,000 and keeps an Outperform rating on the shares.
DIS Disney
$92.59

0.1 (0.11%)

09/26/16
09/26/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Disney (DIS) downgraded to Hold from Buy at Drexel Hamilton with analyst Tony Wible saying he believes a large step up in NBA costs, incremental subscribers losses, difficult studio comps, a riskier studio slate, and Shanghai cost pressures will weigh on fiscal 2017. 2. Twitter (TWTR) downgraded to Underperform from Perform at Oppenheimer with analyst Jason Helfstein saying a media company is the most likely acquirer of Twitter and would not pay meaningfully more than the valuation implied by our price target. 3. RetailMeNot (SALE) downgraded to Sell from Hold at Stifel with analyst Scott Devitt saying third party data indicates that the company's traffic trends have deteriorated recently. 4. Finish Line (FINL) downgraded to Neutral from Buy at Buckingham with the firm's analyst believing shares will be range bound in medium term due to high comp expectations, cost savings will be offset by incentive compensation and other investments, and less compelling valuation. 5. NetApp (NTAP) downgraded to Sell from Hold at Deutsche Bank with analyst Sherri Scribner saying secular challenges in the storage market are not reflected in NetApp's current valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/26/16
UBSW
09/26/16
NO CHANGE
Target $92
UBSW
Neutral
Consumer satisfaction with competitors has caught up to Netflix, says UBS
UBS analyst Doug Mitchelson said that the firm's Evidence Lab survey indicated that U.S. consumer satisfaction with Amazon Prime Video (AMZN) and Hulu - the joint venture owned by Time Warner (TWX), Comcast (CMCSA), 21st Century Fox (FOXA), and Disney (DIS) - has now caught up to Netflix (NFLX), advising that investors should "continue to monitor competitive threats closely" as Netflix leads the category but demand for consumer media time, attention and wallet has intensified. The analyst, who added that Netflix's "pricing power remains unclear" based on the firm's survey work, keeps a Neutral rating and $92 price target on Netflix shares.

TODAY'S FREE FLY STORIES

OXY

Occidental Petroleum

$75.55

0.16 (0.21%)

, HES

Hess Corp.

$52.61

-1.23 (-2.28%)

07:14
01/22/18
01/22
07:14
01/22/18
07:14
Upgrade
Occidental Petroleum, Hess Corp. rating change  »

Occidental Petroleum…

OXY

Occidental Petroleum

$75.55

0.16 (0.21%)

HES

Hess Corp.

$52.61

-1.23 (-2.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 14

    Feb

07:13
01/22/18
01/22
07:13
01/22/18
07:13
General news
Futures lower as government shutdown enters day three »

Stock futures are…

AIG

AIG

$61.55

0.02 (0.03%)

07:12
01/22/18
01/22
07:12
01/22/18
07:12
Hot Stocks
Breaking Hot Stocks news story on AIG 

AIG trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Feb

  • 20

    Feb

  • 21

    Feb

VR

Validus

$46.72

0.81 (1.76%)

07:12
01/22/18
01/22
07:12
01/22/18
07:12
Hot Stocks
Breaking Hot Stocks news story on Validus 

Validus trading resumes

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

REXR

Rexford Industrial

$28.79

0.47 (1.66%)

07:11
01/22/18
01/22
07:11
01/22/18
07:11
Hot Stocks
Rexford Industrial acquires industrial property for $11.4M, sells one for $11.4M »

Rexford Industrial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALK

Alaska Air

$68.88

-0.91 (-1.30%)

, BA

Boeing

$337.73

-2.43 (-0.71%)

07:11
01/22/18
01/22
07:11
01/22/18
07:11
Hot Stocks
Alaska Air names Ray Conner to board »

Alaska Air Group (ALK),…

ALK

Alaska Air

$68.88

-0.91 (-1.30%)

BA

Boeing

$337.73

-2.43 (-0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 31

    Jan

  • 21

    Feb

PCG

PG&E

$44.39

-0.11 (-0.25%)

07:10
01/22/18
01/22
07:10
01/22/18
07:10
Recommendations
PG&E analyst commentary  »

PG&E price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Feb

ENB

Enbridge

$39.39

-0.33 (-0.83%)

, SEP

Spectra Energy Partners

07:10
01/22/18
01/22
07:10
01/22/18
07:10
Hot Stocks
Enbridge, Spectra Energy Partners complete elimination of IDRs »

Enbridge (ENB) and…

ENB

Enbridge

$39.39

-0.33 (-0.83%)

SEP

Spectra Energy Partners

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

OMER

Omeros

$16.70

-0.02 (-0.12%)

07:10
01/22/18
01/22
07:10
01/22/18
07:10
Hot Stocks
Omeros receives positive opinion for OMS721 from EMA »

Omeros Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EIX

Edison International

$62.12

0.2 (0.32%)

07:10
01/22/18
01/22
07:10
01/22/18
07:10
Recommendations
Edison International analyst commentary  »

Edison International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWOU

2U

$72.38

1.49 (2.10%)

07:09
01/22/18
01/22
07:09
01/22/18
07:09
Hot Stocks
2U and WeWork partner in online graduate program expansion »

2U and WeWork Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NQ

NQ Mobile

$3.82

-0.07 (-1.80%)

07:07
01/22/18
01/22
07:07
01/22/18
07:07
Hot Stocks
NQ Mobile proposes to rebrand, change name to "Link Motion Inc." »

NQ Mobile announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

bluebird bio

$175.95

-6.15 (-3.38%)

07:07
01/22/18
01/22
07:07
01/22/18
07:07
Technical Analysis
Technical Take: bluebird bio moves higher »

The stock was last up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

OPB

Opus Bank

$28.70

0.05 (0.17%)

07:07
01/22/18
01/22
07:07
01/22/18
07:07
Earnings
Opus Bank reports Q4 EPS including items 3c, consensus 38c »

Reports net income of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

CQH

Cheniere Energy Partners LP

$28.22

0.22 (0.79%)

, CQP

Cheniere Energy Partners

$30.48

0.2 (0.66%)

07:06
01/22/18
01/22
07:06
01/22/18
07:06
Conference/Events
Morgan Stanley to hold a tour »

Annual Morgan Stanley…

CQH

Cheniere Energy Partners LP

$28.22

0.22 (0.79%)

CQP

Cheniere Energy Partners

$30.48

0.2 (0.66%)

ENLC

EnLink Midstream

$18.75

0.25 (1.35%)

ENLK

EnLink Midstream Partners

$17.45

0.37 (2.17%)

EPD

Enterprise Products

$28.66

0.36 (1.27%)

NBLX

Noble Midstream

$55.10

-0.48 (-0.86%)

PAA

Plains All American

$22.49

-0.09 (-0.40%)

SHLX

Shell Midstream

$30.13

-0.03 (-0.10%)

TRGP

Targa Resources

$50.73

0.04 (0.08%)

WES

Western Gas Partners

$52.31

0.34 (0.65%)

WGP

Western Gas Equity

$40.42

0.5 (1.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 22

    Jan

  • 23

    Jan

  • 07

    Feb

  • 16

    Feb

  • 20

    Feb

REGN

Regeneron

$371.53

0.25 (0.07%)

, SNY

Sanofi

$44.60

0.09 (0.20%)

07:06
01/22/18
01/22
07:06
01/22/18
07:06
Hot Stocks
Regeneron reports approval of Dupixent in Japan for atopic dermatitis »

Regeneron (REGN)…

REGN

Regeneron

$371.53

0.25 (0.07%)

SNY

Sanofi

$44.60

0.09 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 08

    Mar

  • 25

    Mar

  • 02

    May

SLB

Schlumberger

$76.42

0.05 (0.07%)

07:06
01/22/18
01/22
07:06
01/22/18
07:06
Recommendations
Schlumberger analyst commentary  »

Schlumberger price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTNP

Titan Pharmaceuticals

$1.28

0.025 (2.00%)

, BBRX

Braeburn Pharmaceuticals

07:06
01/22/18
01/22
07:06
01/22/18
07:06
Hot Stocks
Titan Pharmaceuticals discussing U.S. Probuphine commercialization with Braeburn »

Titan Pharmaceuticals…

TTNP

Titan Pharmaceuticals

$1.28

0.025 (2.00%)

BBRX

Braeburn Pharmaceuticals

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$54.02

2.42 (4.69%)

, MMM

3M

$248.18

2.27 (0.92%)

07:05
01/22/18
01/22
07:05
01/22/18
07:05
Conference/Events
ASHRAE and AHRI to co-host an expo »

The American Society of…

CC

Chemours

$54.02

2.42 (4.69%)

MMM

3M

$248.18

2.27 (0.92%)

ABB

ABB

$28.01

0.03 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 25

    Jan

  • 15

    Feb

07:05
01/22/18
01/22
07:05
01/22/18
07:05
General news
Oil Action: WTI benchmark futures are fractionally lower »

Oil Action: WTI benchmark…

ACBFF

Aurora Cannabis

$10.77

0.302 (2.89%)

07:05
01/22/18
01/22
07:05
01/22/18
07:05
Hot Stocks
CanniMed announces continuation of discussions with Aurora Cannabis »

CanniMed Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATNX

Athenex

$17.33

0.12 (0.70%)

07:04
01/22/18
01/22
07:04
01/22/18
07:04
Hot Stocks
Athenex announces results of first cohort of Phase 1b clinical trial of Oraxol »

Athenex announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEVB

Level Brands

$5.10

-0.0385 (-0.75%)

07:03
01/22/18
01/22
07:03
01/22/18
07:03
Hot Stocks
Level Brands, Kathy Ireland announce extension of Isodiol license agreement »

Kathy Ireland, Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABAX

Abaxis

$61.16

0.35 (0.58%)

07:03
01/22/18
01/22
07:03
01/22/18
07:03
Hot Stocks
Abaxis granted USDA Approval for new VetScan FLEX4 Rapid Test »

Abaxis' new VetScan…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

QURE

uniQure

$17.99

-0.01 (-0.06%)

07:03
01/22/18
01/22
07:03
01/22/18
07:03
Hot Stocks
uniQure receives OMPD in EU for AMT-130 »

uniQure announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.